Inhibition of Breast Cancer Metastasis Via PITPNM3 by Pachymic Acid

被引：30
|
作者：
Hong, Ri [1 ]
Shen, Min-He [2 ]
Xie, Xiao-Hong [1 ]
Ruan, Shan-Ming [2 ]
机构：
[1] Zhejiang Chinese Med Univ, Sch Clin Med 1, Dept Breast, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Sch Clin Med 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2012年 / 13卷 / 05期
关键词：
Breast cancer; metastasis; MDA-MB-231; PITPNM3; pachymic acid; PORIA-COCOS; CCL18; MACROPHAGES; EXPRESSION; BONE;
D O I：
10.7314/APJCP.2012.13.5.1877
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Breast cancer metastasis is the most common cause of cancer-related death in women. Thus, seeking targets of breast tumor cells is an attractive goal towards improving clinical treatment. The present study showed that CCL18 from tumor-associated macrophages could promote breast cancer metastasis via PITPNM3. In addition, we found that pachymic acid (PA) could dose-dependently inhibit migration and invasion of MDA-MB-231cells, with or without rCCL18 stimulation. Furthermore, evidence was obtained that PA could suppress the phosphorylation of PITPNM3 and the combination of CCL18 and PITPNM3. Therefore, we speculate that PA could inhibit breast cancer metastasis via PITPNM3.
引用
收藏
页码：1877 / 1880
页数：4
相关论文
共 50 条
  • [21] MULTISTEP INHIBITION OF BREAST-CANCER METASTASIS TO BONE
    WILLIAMS, P
    MBALAVIELE, G
    SASAKI, A
    DUNSTAN, C
    ADAMS, R
    BAUSS, F
    MUNDY, GR
    YONEDA, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S169 - S169
  • [22] Inhibition of breast cancer growth and metastasis by a biomimetic peptide
    Lee, Esak
    Lee, Seung Jae
    Koskimaki, Jacob E.
    Han, Zheyi
    Pandey, Niranjan B.
    Popel, Aleksander S.
    SCIENTIFIC REPORTS, 2014, 4
  • [23] Inhibition of breast cancer growth and metastasis by a biomimetic peptide
    Esak Lee
    Seung Jae Lee
    Jacob E. Koskimaki
    Zheyi Han
    Niranjan B. Pandey
    Aleksander S. Popel
    Scientific Reports, 4
  • [24] Inhibition of breast cancer metastasis by deguelin in an experimental model
    Kalra, A. Mit P.
    Gupta, Akash
    Patel, Rutul
    Katta, Harshadadevi
    Hawthorne, Michael
    Murillo, Genoveva
    Mehta, Rajeshwari
    Mehta, Rajendra
    CANCER RESEARCH, 2012, 72
  • [25] Inhibition of Bone Metastasis from Breast Carcinoma by Rosmarinic Acid
    Xu, Yichun
    Jiang, Zijing
    Ji, Guang
    Liu, Jianwen
    PLANTA MEDICA, 2010, 76 (10) : 956 - 962
  • [26] Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun
    Wei Shao
    Shasha Li
    Lu Li
    Kequan Lin
    Xinhong Liu
    Haiyan Wang
    Huili Wang
    Dong Wang
    Protein & Cell, 2019, 10 (03) : 161 - 188
  • [27] Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun
    Shao, Wei
    Li, Shasha
    Li, Lu
    Lin, Kequan
    Liu, Xinhong
    Wang, Haiyan
    Wang, Huili
    Wang, Dong
    PROTEIN & CELL, 2019, 10 (03) : 161 - 177
  • [28] REVERSAL OF EPIGENETIC DYSREGULATION IN BREAST CANCER BRAIN METASTASIS VIA HDAC1/2 INHIBITION
    Luzietti, L.
    Gomez, G.
    Zwart, W.
    Prekovic, S.
    Young, L.
    Damir Vareslija, D.
    NEURO-ONCOLOGY, 2024, 26 : V92 - V92
  • [29] Inhibition of growth and metastasis of breast cancer by targeted delivery of 17-hydroxy-jolkinolide B via hyaluronic acid-coated liposomes
    Liu, Dan
    Zhang, Qi
    Wang, Jing
    Guan, Shuang
    Cai, Defu
    Liu, Jicheng
    CARBOHYDRATE POLYMERS, 2021, 257
  • [30] Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition
    Su, Yan
    Yang, Jin
    Wang, Meng-Meng
    Fang, Hong-Bao
    Liu, Hong-Ke
    Yu, Zheng-Hong
    Su, Zhi
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2024, 251
12345